Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 13 studies | 30% ± 11% | |
interneuron | 6 studies | 31% ± 10% | |
glutamatergic neuron | 5 studies | 33% ± 12% | |
oligodendrocyte precursor cell | 5 studies | 19% ± 2% | |
GABAergic neuron | 5 studies | 38% ± 8% | |
endothelial cell of lymphatic vessel | 4 studies | 34% ± 11% | |
endothelial cell | 3 studies | 36% ± 20% | |
granule cell | 3 studies | 21% ± 5% | |
neuron | 3 studies | 29% ± 8% | |
mesothelial cell | 3 studies | 25% ± 6% | |
ciliated cell | 3 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 8 studies | 25% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 95% | 640.25 | 2508 / 2642 | 99% | 17.59 | 699 / 705 |
uterus | 100% | 2677.19 | 170 / 170 | 78% | 6.58 | 360 / 459 |
prostate | 95% | 765.42 | 233 / 245 | 77% | 2.43 | 386 / 502 |
lung | 79% | 198.27 | 455 / 578 | 76% | 3.35 | 874 / 1155 |
breast | 96% | 423.95 | 441 / 459 | 54% | 1.69 | 606 / 1118 |
ovary | 100% | 3025.96 | 180 / 180 | 50% | 1.53 | 215 / 430 |
intestine | 81% | 263.30 | 786 / 966 | 54% | 2.15 | 283 / 527 |
esophagus | 61% | 134.41 | 883 / 1445 | 72% | 4.22 | 132 / 183 |
bladder | 67% | 146.14 | 14 / 21 | 58% | 2.45 | 294 / 504 |
thymus | 82% | 214.05 | 535 / 653 | 34% | 1.55 | 207 / 605 |
stomach | 52% | 140.58 | 186 / 359 | 60% | 3.63 | 171 / 286 |
spleen | 100% | 1219.52 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 801.21 | 1331 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 781.18 | 1184 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 62% | 139.18 | 159 / 258 | 17% | 0.91 | 38 / 230 |
kidney | 56% | 199.89 | 50 / 89 | 19% | 0.65 | 168 / 901 |
pancreas | 0% | 0.55 | 1 / 328 | 74% | 2.84 | 131 / 178 |
skin | 64% | 206.12 | 1163 / 1809 | 9% | 0.54 | 42 / 472 |
tonsil | 0% | 0 | 0 / 0 | 64% | 3.02 | 29 / 45 |
heart | 46% | 101.58 | 393 / 861 | 0% | 0 | 0 / 0 |
liver | 4% | 5.33 | 8 / 226 | 22% | 1.20 | 91 / 406 |
lymph node | 0% | 0 | 0 / 0 | 21% | 0.99 | 6 / 29 |
muscle | 8% | 14.47 | 65 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 2.98 | 10 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0090083 | Biological process | regulation of inclusion body assembly |
GO_0042417 | Biological process | dopamine metabolic process |
GO_0008219 | Biological process | cell death |
GO_0046928 | Biological process | regulation of neurotransmitter secretion |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0008021 | Cellular component | synaptic vesicle |
GO_0043025 | Cellular component | neuronal cell body |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0036464 | Cellular component | cytoplasmic ribonucleoprotein granule |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
GO_0042802 | Molecular function | identical protein binding |
Gene name | SNCAIP |
Protein name | Synphilin-1e protein (Synuclein alpha interacting protein) Synuclein alpha interacting protein Synphilin-1g protein (Synuclein alpha interacting protein) Synphilin-1d protein (Synuclein alpha interacting protein) Synphilin-1f protein (Synuclein alpha interacting protein) Synphilin-1 (Sph1) (Alpha-synuclein-interacting protein) |
Synonyms | |
Description | FUNCTION: Isoform 2 inhibits the ubiquitin ligase activity of SIAH1 and inhibits proteasomal degradation of target proteins. Isoform 2 inhibits autoubiquitination and proteasomal degradation of SIAH1, and thereby increases cellular levels of SIAH. Isoform 2 modulates SNCA monoubiquitination by SIAH1. . |
Accessions | D6RFL3 ENST00000395469.6 [Q9Y6H5-6] D6RBR2 Q6L980 ENST00000512385.5 ENST00000510658.5 Q6L983 ENST00000261368.13 [Q9Y6H5-1] ENST00000395466.6 Q9Y6H5 ENST00000509154.6 ENST00000514467.5 ENST00000508681.5 ENST00000261367.11 [Q9Y6H5-3] ENST00000508017.5 D6RD29 D6R9G8 D6REC1 ENST00000509652.1 ENST00000542191.5 ENST00000506272.5 Q6L982 ENST00000514497.6 ENST00000509023.5 ENST00000515215.6 ENST00000512146.6 Q6L981 D6RHX3 |